FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)
FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)
What to do next
Read the issuing agency's notice carefully, compare the product identifiers, and follow the official remedy instructions. RecallDefense helps you keep watch, but the source agency's notice is the authority for action.
Source attribution: FDA. Published Jun 30, 2022.
